30 June 2016

Gernandt & Danielsson advises in Moberg Pharma AB (publ)’s issue of subsequent bonds

The listed pharmaceutical company Moberg Pharma AB (publ) has decided to issue subsequent corporate bonds with a nominal value of SEK 85 million, under the company’s outstanding bonds with a frame of SEK 600 million. The company has undertaken to list the bonds on Nasdaq Stockholm.

Gernandt & Danielsson has advised the company and its financial advisor Carnegie Investment Bank AB (publ) and Swedbank AB (publ) with a team consisting of Partner Mikael Borg, Senior Associate Adrian Della Morte Pålstam and Associate Katarina Odelberg.

Print